Your browser doesn't support javascript.
loading
COSMIC-dFBA: A novel multi-scale hybrid framework for bioprocess modeling.
Gopalakrishnan, Saratram; Johnson, William; Valderrama-Gomez, Miguel A; Icten, Elcin; Tat, Jasmine; Ingram, Michael; Fung Shek, Coral; Chan, Pik K; Schlegel, Fabrice; Rolandi, Pablo; Kontoravdi, Cleo; Lewis, Nathan E.
Afiliação
  • Gopalakrishnan S; Department of Pediatrics, University of California San Diego, USA.
  • Johnson W; Process Development, Amgen, USA.
  • Valderrama-Gomez MA; Process Development, Amgen, USA.
  • Icten E; Process Development, Amgen, USA.
  • Tat J; Process Development, Amgen, USA.
  • Ingram M; Process Development, Amgen, USA.
  • Fung Shek C; Process Development, Amgen, USA.
  • Chan PK; Process Development, Amgen, USA.
  • Schlegel F; Process Development, Amgen, USA.
  • Rolandi P; Process Development, Amgen, USA.
  • Kontoravdi C; Department of Chemical Engineering, Imperial College London, UK.
  • Lewis NE; Department of Pediatrics, University of California San Diego, USA; Department of Bioengineering, University of California San Diego, USA. Electronic address: nlewisres@ucsd.edu.
Metab Eng ; 82: 183-192, 2024 Mar.
Article em En | MEDLINE | ID: mdl-38387677
ABSTRACT
Metabolism governs cell performance in biomanufacturing, as it fuels growth and productivity. However, even in well-controlled culture systems, metabolism is dynamic, with shifting objectives and resources, thus limiting the predictive capability of mechanistic models for process design and optimization. Here, we present Cellular Objectives and State Modulation In bioreaCtors (COSMIC)-dFBA, a hybrid multi-scale modeling paradigm that accurately predicts cell density, antibody titer, and bioreactor metabolite concentration profiles. Using machine-learning, COSMIC-dFBA decomposes the instantaneous metabolite uptake and secretion rates in a bioreactor into weighted contributions from each cell state (growth or antibody-producing state) and integrates these with a genome-scale metabolic model. A major strength of COSMIC-dFBA is that it can be parameterized with only metabolite concentrations from spent media, although constraining the metabolic model with other omics data can further improve its capabilities. Using COSMIC-dFBA, we can predict the final cell density and antibody titer to within 10% of the measured data, and compared to a standard dFBA model, we found the framework showed a 90% and 72% improvement in cell density and antibody titer prediction, respectively. Thus, we demonstrate our hybrid modeling framework effectively captures cellular metabolism and expands the applicability of dFBA to model the dynamic conditions in a bioreactor.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Reatores Biológicos / Modelos Biológicos Idioma: En Revista: Metab Eng Assunto da revista: ENGENHARIA BIOMEDICA / METABOLISMO Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Reatores Biológicos / Modelos Biológicos Idioma: En Revista: Metab Eng Assunto da revista: ENGENHARIA BIOMEDICA / METABOLISMO Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos